Tildrakizumab (SCH 900222) is a potent humanized monoclonal antibody targeting the p19 subunit of IL-23 with a Kd value of 136 pM, useful for studying psoriasis.
Molecular Weight:
144.4 (kDa)
CAS Number:
[1326244-10-3]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted